GGrantIndex
Sort

78,016 grants matching breast cancer

Functional Cooperation of Tissue Factor and Integrins

$474,750
Wolfram Ruf · Scripps Research Institute, The · R01 · FY2009 · HL

Functional Cooperation of Tissue Factor and Integrins

$474,750
Wolfram Ruf · Scripps Research Institute, The · R01 · FY2012 · HL

Functional Cooperation of Tissue Factor and Integrins

$474,750
Wolfram Ruf · Scripps Research Institute, The · R01 · FY2011 · HL

Functional Cooperation of Tissue Factor and Integrins

$474,750
Wolfram Ruf · Scripps Research Institute, The · R01 · FY2010 · HL

IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE

$474,718
Richard D Gelber · Dana-Farber Cancer Inst · U24 · FY2009 · CA

The Two Sister Study

$474,716
Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

MISMATCH REPAIR LOSS RENDERS ER+/HER2- BREAST CANCER SUSCEPTIBLE TO HER2/3 INHIBITION

$474,709
Baylor College Of Medicine · · FY2018 · Defense Health Agency

Simultaneous Emission and Transmission Mammotomography

$474,660
Duke University · R01 · FY2004 · CA

Combating Subclonal Evolution of Resistant Cancer Phenotypes

$474,644
Andrea Hope Bild · University Of Utah · U54 · FY2017 · CA

Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation

$474,621
Guangwen Ren · Jackson Laboratory · R01 · FY2023 · CA

Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation

$474,620
Guangwen Ren · Jackson Laboratory · R01 · FY2022 · CA

MISMATCH REPAIR LOSS RENDERS ER+/HER2- BREAST CANCER SUSCEPTIBLE TO HER2/3 INHIBITION

$474,592
Sanford Burnham Prebys Medical Discovery Institute · · FY2018 · Department of the Army

Genomic and Transcriptomic Analysis of Mammographic Density

$474,559
Weiva Sieh · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

ESTABLISHING MICROTUBULE ACETYLATION AS A PRIME THERAPEUTIC TARGET FOR INVASIVE BREAST CANCER

$474,549
The Leland Stanford Junior University · · FY2011 · Department of Defense

Targeting Metabolic Vulnerabilities of Triple Negative Breast Cancer Stem Cells

$474,547
Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Targeting Metabolic Vulnerabilities of Triple Negative Breast Cancer Stem Cells

$474,547
Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian Reserve

$474,524
Kutluk H Oktay · Yale University · R01 · FY2018 · HD

Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian Reserve

$474,524
Kutluk H Oktay · Yale University · R01 · FY2019 · HD

Acupuncture for Aromatase Inhibitor-Related Arthralgias in Breast Cancer Patients

$474,523
Dawn Hershman · Columbia University Health Sciences · R01 · FY2015 · AT

Defining and Targeting Homologous Recombination Deficiency in Breast Cancer

$474,520
Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers

$474,511
Joshua James Gruber · Ut Southwestern Medical Center · R01 · FY2024 · CA

Shared Instrumentation Grant

$474,500
William Richard McCombie · Cold Spring Harbor Laboratory · S10 · FY2009 · RR

The Southeastern Consortium for Microscopy of MacroMolecular Machines

$474,492
Kenneth A Taylor · Florida State University · U24 · FY2017 · GM

The Southeastern Consortium for Microscopy of MacroMolecular Machines

$474,492
Kenneth A Taylor · Florida State University · U24 · FY2020 · GM

The Southeastern Consortium for Microscopy of MacroMolecular Machines

$474,492
Kenneth A Taylor · Florida State University · U24 · FY2019 · GM